Insiders Gilead Sciences, Inc.

Equities

GILD

US3755581036

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2025-07-14 pm EDT			Pre-market 09:11:05 am
112.09 ^USD	+2.23%		111.26	-0.74%

Jul. 14	Gilead Says Yeztugo Shows Broad Effectiveness, Tolerability for Diverse HIV Prevention	MT
Jul. 14	Gilead Presents New Data on Twice-Yearly Lenacapavir (Yeztugo®) for Hiv Prevention At Ias 2025	CI

Insiders

Pharos Energy Names New Nonexecutive Chair	Jun. 26	MT
Xponential Fitness, Inc. Appoints Lily Yang to its Board of Directors, Effective June 16, 2025	Jun. 17	CI
Gilead Sciences Insider Sold Shares Worth $1,104,193, According to a Recent SEC Filing	Jun. 03	MT
Gilead Sciences Insider Sold Shares Worth $3,010,564, According to a Recent SEC Filing	May. 23	MT
Pharos Energy plc Announces Intention of John Martin to Stand Down as Non-Executive Chair	May. 22	CI
Compugen Ltd. Announces Management Changes	May. 13	CI
Compugen Ltd. Announces Chief Executive Officer Changes	May. 13	CI
Arrivent Biopharma Inc Appoints Merdad Parsey to Its Board of Directors	Apr. 28	CI
Zymeworks Inc. Announces Appointment of Sabeen Mekan, M.D., as Senior Vice President, Clinical Development	Apr. 21	CI
Gilead Sciences Insider Sold Shares Worth $266,000, According to a Recent SEC Filing	Apr. 16	MT
Ocado Group CEO to Temporarily Serve as Head of Ocado Solutions	Apr. 16	MT
UK's Ocado CEO Steiner temporarily takes helm of tech division	Apr. 16	RE
Cosmo Pharmaceuticals N.V. Appoints Federico Sommariva as Chief Legal Counsel	Apr. 01	CI
Nurix Therapeutics Appoints Roy D. Baynes to Its Board of Directors	Mar. 13	CI
Gilead Sciences, Inc. Announces Executive Changes	Mar. 12	CI
Aadi Bioscience Appoints David Dornan, Phd, as Chief Scientific Officer	Feb. 18	CI
Gilead Sciences Insider Sold Shares Worth $14,073,241, According to a Recent SEC Filing	Feb. 14	MT
Gilead Sciences Insider Sold Shares Worth $13,822,740, According to a Recent SEC Filing	Feb. 04	MT
Adicet Bio, Inc. Announces Executive Changes	Dec. 18	CI
Gilead Sciences Names Sanofi's Berger as Next Chief Medical Officer	Dec. 12	DJ
Gilead appoints Sanofi official Dietmar Berger as next chief medical officer	Dec. 12	RE
Gilead Sciences Names Dietmar Berger as Chief Medical Officer	Dec. 12	MT
Gilead Sciences, Inc. Announces Chief Medical Officer Changes	Dec. 12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Time To Grow PFL Fanbase, Revenue: CEO John Martin

July 11, 2025 at 04:09 am EDT